Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 23304907)

1.

Barriers to and facilitators of antiretroviral therapy adherence in Nepal: a qualitative study.

Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E.

J Health Popul Nutr. 2012 Dec;30(4):410-9.

2.

Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study.

Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E.

PLoS One. 2012;7(5):e35547. doi: 10.1371/journal.pone.0035547. Epub 2012 May 1.

3.

Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.

Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM, Bimirew MA, Kassie DM.

PLoS One. 2014 May 14;9(5):e97353. doi: 10.1371/journal.pone.0097353. eCollection 2014.

4.

Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study.

Kumarasamy N, Safren SA, Raminani SR, Pickard R, James R, Krishnan AK, Solomon S, Mayer KH.

AIDS Patient Care STDS. 2005 Aug;19(8):526-37.

PMID:
16124847
5.

"It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting.

Watt MH, Maman S, Earp JA, Eng E, Setel PW, Golin CE, Jacobson M.

Soc Sci Med. 2009 May;68(10):1793-800. doi: 10.1016/j.socscimed.2009.02.037. Epub 2009 Mar 28.

6.
7.

Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme.

Krummenacher I, Spencer B, Du Pasquier S, Bugnon O, Cavassini M, Schneider MP.

Int J Clin Pharm. 2014 Aug;36(4):716-24. doi: 10.1007/s11096-014-9930-0. Epub 2014 Jun 10.

PMID:
24913358
8.

Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective.

Lyimo RA, de Bruin M, van den Boogaard J, Hospers HJ, van der Ven A, Mushi D.

BMC Public Health. 2012 Aug 30;12:716. doi: 10.1186/1471-2458-12-716.

9.
10.

"If I have nothing to eat, I get angry and push the pills bottle away from me": A qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo.

Musumari PM, Feldman MD, Techasrivichien T, Wouters E, Ono-Kihara M, Kihara M.

AIDS Care. 2013;25(10):1271-7. doi: 10.1080/09540121.2013.764391. Epub 2013 Feb 6.

PMID:
23383757
11.

Barriers and facilitators of retention in HIV care and treatment services in Iringa, Tanzania: the importance of socioeconomic and sociocultural factors.

Tomori C, Kennedy CE, Brahmbhatt H, Wagman JA, Mbwambo JK, Likindikoki S, Kerrigan DL.

AIDS Care. 2014;26(7):907-13. doi: 10.1080/09540121.2013.861574. Epub 2013 Nov 27.

PMID:
24279762
12.

Refining a personalized mHealth intervention to promote medication adherence among HIV+ methamphetamine users.

Montoya JL, Georges S, Poquette A, Depp CA, Atkinson JH, Moore DJ; Translational Methamphetamine AIDS Research Center (TMARC) Group.

AIDS Care. 2014;26(12):1477-81. doi: 10.1080/09540121.2014.924213. Epub 2014 Jun 9.

PMID:
24911433
13.

Understanding reasons for treatment interruption amongst patients on antiretroviral therapy--a qualitative study at the Lighthouse Clinic, Lilongwe, Malawi.

Tabatabai J, Namakhoma I, Tweya H, Phiri S, Schnitzler P, Neuhann F.

Glob Health Action. 2014 Sep 30;7:24795. doi: 10.3402/gha.v7.24795. eCollection 2014.

14.

Livelihood experiences and adherence to HIV antiretroviral therapy among participants in a food assistance pilot in Bolivia: a qualitative study.

Palar K, Martin A, Oropeza Camacho ML, Derose KP.

PLoS One. 2013 Apr 16;8(4):e61935. doi: 10.1371/journal.pone.0061935. Print 2013.

15.

Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study.

Sabin LL, Desilva MB, Hamer DH, Keyi X, Yue Y, Wen F, Tao L, Heggenhougen HK, Seton L, Wilson IB, Gill CJ.

AIDS Care. 2008 Nov;20(10):1242-50. doi: 10.1080/09540120801918651.

16.

Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option?

Gusdal AK, Obua C, Andualem T, Wahlstrom R, Tomson G, Peterson S, Ekstrom AM, Thorson A, Chalker J, Fochsen G; INRUD-IAA project.

AIDS Care. 2009 Nov;21(11):1381-7. doi: 10.1080/09540120902883119.

PMID:
20024714
17.

Acceptability of a group intervention for initiates of antiretroviral therapy in Tanzania.

Watt MH, Aronin EH, Maman S, Thielman N, Laiser J, John M.

Glob Public Health. 2011;6(4):433-46. doi: 10.1080/17441692.2010.494162.

18.

Understanding the facilitators and barriers of antiretroviral adherence in Peru: a qualitative study.

Curioso WH, Kepka D, Cabello R, Segura P, Kurth AE.

BMC Public Health. 2010 Jan 13;10:13. doi: 10.1186/1471-2458-10-13.

19.

Antiretroviral therapy drug adherence in Rwanda: perspectives from patients and healthcare workers using a mixed-methods approach.

Vyankandondera J, Mitchell K, Asiimwe-Kateera B, Boer K, Mutwa P, Balinda JP, van Straten M, Reiss P, van de Wijgert J.

AIDS Care. 2013;25(12):1504-12. doi: 10.1080/09540121.2013.779626. Epub 2013 Mar 21.

PMID:
23517180
20.

Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: insights from a qualitative study.

Fetzer BC, Mupenda B, Lusiama J, Kitetele F, Golin C, Behets F.

AIDS Patient Care STDS. 2011 Oct;25(10):611-21. doi: 10.1089/apc.2011.0083. Epub 2011 Aug 8.

PMID:
21823909
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk